ARTICLE | Distillery Therapeutics
Decreasing DDIT3 to treat fatty liver disease
October 27, 2021 4:57 PM UTC
DISEASE CATEGORY: Hepatic
INDICATION: Liver disease...
BCIQ Target Profiles
DNA-damage-inducible transcript 3 (DDIT3) (CHOP10) (CHOP) (GADD153)